Solstice Biologics Overview

  • Founded
  • 2012
  • Status
  • Out of Business
  • Employees
  • 18
  • Latest Deal Type
  • Out of Business

Solstice Biologics General Information


Developer of RNAi pro-drugs designed to solve the problem of targeting and delivery of nucleic acid therapeutics. The company's drug uses a small double-stranded cellular RNA that selects the specific mRNAs to degrade, enabling researchers to develop cell-permeable drugs that can enter many different cell types.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Primary Industry
Drug Discovery
Other Industries
Primary Office
  • 9535 Waples Street
  • Suite 100
  • San Diego, CA 92121
  • United States
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Solstice Biologics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Out of Business 26-Jul-2016 000.00 Completed Out of Business
3. Early Stage VC (Series A) 30-Dec-2015 000 000.00 Completed Generating Revenue
2. Early Stage VC 02-Oct-2014 $7.5M $25.5M Completed Generating Revenue
1. Early Stage VC (Series A) 04-Jan-2013 $18M $18M Completed Generating Revenue
To view Solstice Biologics’s complete valuation and funding history, request access »

Solstice Biologics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial